DNA-PK inhibition enhances neoantigen diversity and increases T cell responses to immunoresistant tumors.
Nielsen AJ, Albert GK, Sanchez A, Chen J, Liu J, Davalos AS, Geng D, Bradeen X, Hintzsche JD, Robinson W, McCarter M, Amato C, Tobin R, Couts K, Wilky BA, Davila E.
Nielsen AJ, et al. Among authors: amato c.
J Clin Invest. 2024 Oct 22;134(24):e180278. doi: 10.1172/JCI180278.
J Clin Invest. 2024.
PMID: 39436696
Free PMC article.